Schizophrenia is a chronic and debilitating mental illness that affects about 1 percent of the population worldwide, casting a long shadow over the lives of individuals and their families. It’s a ...
Schizophrenia Review As of 2013 and the DSM-5, schizophrenia is no longer subtyped, as sufferers often have cross-subtype symptomatology. Those familiar will know, for instance, it’s not unusual to ...
Schizophrenia—incoherent activity, paranoia, talking gibberish to people who aren’t there, perhaps some catatonia, right? Partially. Schizophrenia review As of 2013 and the DSM-5, schizophrenia is no ...
Morning Overview on MSN
Study links schizophrenia gene to decision-making, researchers report
Researchers have found statistically significant links between a gene tied to schizophrenia risk and poorer cognitive ...
Today, the Food and Drug Administration approved the first new type of drug for schizophrenia in decades. It's called KarXT, and its main advantage is that it has fewer side effects than current drugs ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results